NCT01642732 2017-05-30
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 1 Terminated
University of Michigan Rogel Cancer Center
Pharmatech
Proton Collaborative Group
GP-Pharm